Abstract
It is estimated that cigarette smoking kills over 1 000 000 people each year by causing lung cancer as well as many other neoplasmas. p53 mutations are frequent in tobacco-related cancers and the mutation load is often higher in cancers from smokers than from nonsmokers. In lung cancers, the p53 mutational patterns are different between smokers and nonsmokers with an excess of G to T transversions in smoking-associated cancers. The prevalence of G to T transversions is 30% in smokers’ lung cancer but only 12% in lung cancers of nonsmokers. A similar trend exists, albeit less marked, in laryngeal cancers and in head and neck cancers. This type of mutation is infrequent in most other tumors aside from hepatocellular carcinoma. At several p53 mutational hotspots common to all cancers, such as codons 248 and 273, a large fraction of the mutations are G to T events in lung cancers but are almost exclusively G to A transitions in non-tobacco-related cancers. Two important classes of tobacco smoke carcinogens are the polycyclic aromatic hydrocarbons (PAH) and the nicotine-derived nitrosamines. Recent studies have indicated that there is a strong coincidence of G to T transversion hotspots in lung cancers and sites of preferential formation of PAH adducts along the p53 gene. Endogenously methylated CpG dinucleotides are the preferred sites for G to T transversions, accounting for more than 50% of such mutations in lung tumors. The same dinucleotide, when present within CpG-methylated mutational reporter genes, is the target of G to T transversion hotspots in cells exposed to the model PAH compound benzo[a]pyrene-7,8-diol-9,10-epoxide. As summarized here, a number of other tobacco smoke carcinogens also can cause G to T transversion mutations. The available data suggest that p53 mutations in lung cancers can be attributed to direct DNA damage from cigarette smoke carcinogens rather than to selection of pre-existing endogenous mutations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Armstrong RN . 1997 Comprehensive Toxicology: Biotransformation. Vol 3. Guengerich FP (ed) New York: Elsevier Science pp. 307–327
Arora A, Willhite C, Liebler D . 2001 Carcinogenesis 22: 1173–1178
Asami S, Manabe H, Miyake J, Tsurudome Y, Hirano T, Yamaguchi R, Itoh H, Kasai H . 1997 Carcinogenesis 18: 1763–1766
Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Sheilds PG, Harris CC . 1999 J. Pathol. 187: 8–18
Besarati Nia A, Kleinjans JC, Van Schooten FJ . 2002a Biomarkers 7: 209–229
Besarati Nia A, Bates SE, Pfeifer GP . 2002b Cancer Res. 62: (in press)
Bigger C, St John J, Yagi H, Jerina D, Dipple A . 1992 Proc. Natl. Acad. Sci. USA 89: 368–372
Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA, Sidransky D . 1995 New Engl. J. Med. 332: 712–717
Burchell B, McGurk K, Brierley C, Clarke D . 1997 Comprehensive Toxicology: Biotransformation. Vol 3. Guengerich FP (ed) New York: Elsevier Science pp. 401–436
Burney S, Caulfield J, Niles J, Wishnok J, Tannenbaum S . 1999 Mutation Res. 424: 37–49
Carmical J, Zhang M, Nechev L, Harris C, Harris T, Lloyd R . 2000 Chem. Res. Toxicol. 13: 18–25
Casale G, Singhal M, Bhattacharya S, Ramanathan R, Roberts K, Barbacci D, Zhao J, Jankowiak R, Gross M, Cavalieri E, Small G, Rennard S, Mumford J, Shen M . 2001 Chem. Res. Toxicol. 14: 192–201
Castelao J, Yuan J, Skipper P, Tannenbaum S, Gago-Dominguez M, Crowder J, Ross R, Yu M . 2001 J. Natl. Cancer Inst. 93: 538–545
Chao A, Thun M, Jacobs E, Henley S, Rodriguez C, Calle E . 2000 J. Natl. Cancer Inst. 92: 1888–1896
Chen JX, Zheng Y, West M, Tang M-S . 1998 Cancer Res. 58: 2070–2075
Chen R-H, Maher VM, McCormick JJ . 1990 Proc. Natl. Acad. Sci. USA 87: 8680–8684
Chepiga T, Morton M, Murphy P, Avalos J, Bombick B, Doolittle D, Borgerding M, Swauger J . 2000 Food Chem. Toxicol. 38: 949–962
Chung F, Zhang L, Ocando J, Nath R . 1999 Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis. Singer B and Bartsch H (eds) Lyon, France: International Agency for Research on Cancer pp. 45–54
Conney A . 1982 Cancer Res. 42: 4875–4917
Culp S, Gaylor D, Sheldon W, Goldstein L, Beland F . 1998 Carcinogenesis 19: 117–124
Culp S, Roberts D, Talaska G, Lang N, Fu P, Lay Jr J, Teitel C, Snawder J, Von Tungeln L, Kadlubar F . 1997 Mutation Res. 378: 97–112
Das A, Tan KS, Gopalakrishnan S, Waring MJ, Tomasz M . 1999 Chem. Biol. 6: 461–471
Delclos K, Kadlubar F . 1997 Comprehensive Toxicology: Chemical Carcinogens and Anticarcinogens. 12th edn. Bowden GT and Fischer SM (eds). pp. 141–170
DeMarini DM, Landi S, Tian D, Hanley NM, Li X, Hu F, Roop BC, Mass MJ, Keohavong P, Gao W, Olivier M, Hainaut P, Mumford JL . 2001 Cancer Res. 61: 6679–6681
Denissenko MF, Chen JX, Tang MS, Pfeifer GP . 1997 Proc. Natl. Acad. Sci. USA 94: 3893–3898
Denissenko MF, Pao A, Pfeifer GP, Tang M-S . 1998 Oncogene 16: 1241–1247
Denissenko MF, Pao A, Tang M-S, Pfeifer GP . 1996 Science 274: 430–432
Deutsch-Wenzel R, Brune H, Grimmer G, Dettbarn G, Misfield J . 1983 J. Natl. Cancer Inst. 71: 539–543
Doll R . 1996 Br. Med. J. 52: 35–49
Duffel M . 1997 Comprehensive Toxicology: Biotransformation. Vol 3. Guengerich FP (ed) New York: Elsevier Science pp. 365–384
Eisenstadt E, Warren AJ, Porter J, Atkins D, Miller JH . 1982 Proc. Natl. Acad. Sci. USA 79: 1945–1949
Feng Z, Hu W, Rom WN, Beland FA, Tang M-S . 2002 Biochemistry 41: 6414–6421
Foiles PG, Akerkar SA, Carmella SG, Kagan M, Stoner GD, Resau JH, Hecht SS . 1991 Chem. Res. Toxicol. 4: 364–368
Geacintov NE . 1986 Carcinogenesis 7: 759–766
Greenblatt MS, Bennett WP, Hollstein M, Harris CC . 1994 Cancer Res. 54: 4855–4878
Guengerich F . 2001 Chem. Res. Toxicol. 14: 611–650
Guengerich F, Kim D . 1991 Chem. Res. Toxicol. 4: 413–421
Gupta R, Arif J, Gairola C . 1999 Mutation Res. 424: 195–205
Hainaut P, Hollstein M . 2000 Adv. Cancer Res. 77: 81–137
Hainaut P, Olivier M, Pfeifer GP . 2001 Mutagenesis 16: 551–553
Hainaut P, Pfeifer GP . 2001 Carcinogenesis 22: 367–374
Hanahan D, Weinberg R . 2000 Cell 100: 57–70
Harley N, Cohen B, Tso T . 1980 Banbury Report 3: A Safe Cigarette? Gori GB and Beck FG (eds) Cold Spring Harbor Laboratory pp. 93–104
Hecht S, Hoffmann D . 1988 Carcinogenesis 9: 875–884
Hecht S, Rivenson A, Braley J, DiBello J, Adams J, Hoffmann D . 1986 Cancer Res. 46: 4162–4166
Hecht S, Tricker A . 1999 III. Analytical Determination of Nicotine and Related Compounds and Their Metabolites. Gorrod JW and Jacob P (eds) Amsterdam: Elsevier Science pp. 421–488
Hecht SS . 1998 Chem. Res. Toxicol. 11: 559–603
Hecht SS . 1999 J. Natl. Cancer Inst. 91: 1194–1210
Henderson P, Delaney J, Gu F, Tannenbaum S, Essigmann J . 2002 Biochemistry 41: 914–921
Hernandez-Boussard TM, Hainaut P . 1998 Environ. Health Perspect. 106: 385–391
Hoeijmakers JH . 2001 Nature 411: 366–374
Hoffmann D, Hecht S . 1990 Handbook of Experimental Pharmacology. 94/1 ed. Cooper CS and Grover PL (eds) Heidelberg: Springer-Verlag pp. 63–102
Hoffmann D, Hoffmann I, El-Bayoumy K . 2001 Chem. Res. Toxicol. 14: 767–790
Hollstein M, Sidransky D, Vogelstein B, Harris CC . 1991 Science 253: 49–53
Husgafvel-Pursiainen K, Kannio A . 1996 Environ. Health Perspect. 104: Suppl. 3 553–556
Hussain SP, Amstad P, Raja K, Sawyer M, Hofseth L, Shields PG, Hewer A, Phillips DH, Ryberg D, Haugen A, Harris CC . 2001 Cancer Res. 61: 6350–6355
Hussain SP, Harris CC . 1998 Cancer Res. 58: 4023–4037
International Agency for Research on Cancer. 1972 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. Vol 1 Lyon, France: IARC
International Agency for Research on Cancer. 1973 IARC Monographs on the Carcinogenic Risk of Chemicals to Man. Vol 4 Lyon, France: IARC pp. 127–136
International Agency for Research on Cancer. 1974a IARC Monographs on the Carcinogenic Risk of Chemicals to Man. Vol 7 Lyon, France: IARC pp. 111–140
International Agency for Research on Cancer. 1974b IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 4 Lyon, France: IARC pp. 97–111
International Agency for Research on Cancer. 1978 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Vol 17 Lyon, France: IARC pp. 83–124
International Agency for Research on Cancer. 1982 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 29 Lyon, France: IARC pp. 93–148
International Agency for Research on Cancer. 1983 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 32 Lyon, France: IARC pp. 211–224
International Agency for Research on Cancer. 1985 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 36 Lyon, France: IARC pp. 101–132
International Agency for Research on Cancer. 1986a IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 60 Lyon, France: IARC pp. 73–159
International Agency for Research on Cancer. 1986b IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 38 Lyon, France: IARC pp. 37–375
International Agency for Research on Cancer. 1992 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 54 Lyon, France: IARC pp. 237–285
International Agency for Research on Cancer. 1999 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 71 Lyon, France: IARC pp. 109–225
Johnson RE, Prakash S, Prakash L . 1999 Science 283: 1001–1004
Koc H, Tretyakova N, Walker V, Henderson R, Swenberg J . 1999 Chem. Rev. Toxicol. 12: 566–574
Koivisto P, Kilpelainen I, Rasanen I, Adler I, Pacchierotti F, Peltonen K . 1999 Carcinogenesis 20: 1253–1259
Kozack R, Seo K, Jelinsky S, Loechler E . 2000 Mutation Res. 450: 41–59
Kriek E, Rojas M, Alexandrov K, Bartsch H . 1998 Mutation Res. 400: 215–231
Kunkel T . 1984 Proc. Natl. Acad. Sci. USA 81: 1494–1498
Lin D, Lay JO, Bryant MS, Malaveille C, Friesen M, Bartsch H, Lang NP, Kadlubar FF . 1994 Environ. Health Perspect. 102: Suppl. 6 11–16
Livneh Z . 2001 J. Biol. Chem. 276: 25639–25642
Loechler E, Green C, Essigmann J . 1984 Proc. Natl. Acad. Sci. USA 81: 6271–6275
Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, Araki M, Iwai S, Takio K, Hanaoka F . 1999 Nature 399: 700–704
Mazur M, Glickman B . 1988 Somat. Cell Mol. Genet. 14: 393–400
McCoy G, Wynder E . 1979 Cancer Res. 39: 2844–2850
Melchior Jr W, Marques M, Beland F . 1994 Carcinogenesis 15: 889–899
Melikian A, Amin S, Huie K, Hecht S, Harvey R . 1988 Cancer Res. 48: 1781–1787
Melikian A, Fudem Goldin B, Prahalad A, Hecht S . 1990 Chem. Res. Toxicol. 3: 139–143
Miller J . 1994 Drug Metabol. Dispos. 26: 1–36
Misra R, Page J, Smith G, Waalkes M, Dipple A . 1998 Chem. Res. Toxicol. 11: 211–216
Moriya M . 1993 Proc. Natl. Acad. Sci. USA 90: 1122–1126
Nair J, Barbin A, Velic I, Bartsch H . 1999 Mutation Res. 424: 59–69
National Toxicology Program. 1986 NTP Technical Report No. 289, Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies) National Toxicology Program
Nesnow S, Ross J, Stoner G, Mass M . 1995 Toxicology 103: 403–413
Noori P, Hou S . 2001 Carcinogenesis 22: 1825–1830
Ory K, Legros Y, Auguin C, Soussi T . 1994 EMBO J. 13: 3496–3504
Paschke T . 2000 Mutagenesis 15: 457–458
Pauly GT, Peterson LA, Moschel RC . 2002 Chem. Res. Toxicol. 15: 165–169
Penning T, Burczynski M, Hung C, McCoull K, Palackal N, Tsuruda L . 1999 Chem. Res. Toxicol. 12: 1–18
Pfeifer GP . 2000 Mutat. Res. 450: 155–166
Pfeifer GP, Denissenko MF . 1998 Environ. Mol. Mutagen. 31: 197–205
Phillips DH . 1983 Nature 303: 468–472
Preussmann R, Stewart B . 1984 Chemical Carcinogens. 2nd ed. Vol 2. ACS Monograph 182. Searle CE (ed) Washington, DC: American Chemical Society pp. 643–828
Proctor RN . 2001 Nature Reviews Cancer 1: 82–86
Pryor W . 1997 Environ. Health Perspect. 105: 875–882
Recio L, Saranko C, Steen A . 2000 Res. Rep. Health Eff. Inst. 49–87
Reznik-Shuller H . 1983 Comparative Respiratory Tract Carcinogens 2nd edn Reznik-Shuller HM (ed) Boca Raton, FL: CRC Press pp. 109–159
Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht S . 1988 Cancer Res. 48: 6912–6917
Rodin SN, Rodin AS . 2000 Proc. Natl. Acad. Sci. USA 97: 12244–12249
Rojas M, Alexandrov K, Cascarbi I, Brockmoller J, Likhachev A, Pozharisski K, Bouvier G, Auburtin G, Mayer L, Koop-Schneider A, Roots I, Bartsch H . 1998 Pharmacogenetics 8: 109–118
Ronai ZA, Gradia S, Peterson LA, Hecht SS . 1993 Carcinogenesis 14: 2419–2422
Ross J, Nesnow S . 1999 Mutation Res. 424: 155–166
Rubin H . 2001 Carcinogenesis 22: 1903–1930
Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJP . 1993 Proc. Natl. Acad. Sci. USA 90: 1013–1017
Santella R . 1999 Cancer Epidemiol. Biomarkers Prev. 8: 733–739
Schüller H, Jorquera R, Reichert A, Castonguay A . 1993 Cancer Res. 53: 2498–2501
Sellakumar A, Shubik P . 1974 J. Natl. Cancer Inst. 53: 1713–1719
Seo K, Jelinsky S, Loechler E . 2000 Mutation Res. 463: 215–246
Singer B, Grunberger D . 1983 Molecular Biology of Mutagens and Carcinogens New York: Plenum Press pp. 45–94
Smith LE, Denissenko MF, Bennett WP, Li H, Amin S, Tang M-S, Pfeifer GP . 2000 J. Natl. Cancer Inst. 92: 803–811
Snook M, Severson R, Arrendale R, Higman H, Chortyk O . 1978 Beiträge Tabakforsch. 9: 222–247
Sodum R, Fiala E . 1998 Chem. Res. Toxicol. 11: 1453–1459
Solt D, Polverini P, Claderon L . 1987 J. Oral Path. 16: 294–302
Spiegelhalder B, Bartsch H . 1996 Eur. J. Cancer Prev. 5: 33–38
Swenberg J, Bogdanffy M, Ham A, Holt S, Kim A, Morinello E, Ranasinghe A, Scheller N, Upton P . 1999 IARC Sci. Publ. 29–43
Swenberg J, Kerns W, Mitchell R, Gralla J, Pavkov K . 1980 Cancer Res. 40: 3398–3402
Szeliga J, Dipple A . 1998 Chem. Res. Toxicol. 11: 1–11
Tang D, Phillips D, Stampfer M, Mooney L, Hsu Y, Cho S, Tsai W, Ma J, Cole K, She M, Perera F . 2001 Cancer Res. 61: 6708–6712
Thornton-Manning JR, Dahl AR, Bechtold WE, Griffith Jr WC, Henderson RF . 1995 Carcinogenesis 16: 1723–1731
Tornaletti S, Pfeifer GP . 1995 Oncogene 10: 1493–1499
Tretyakova N, Lin Y, Sangaiah R, Upton P, Swenberg J . 1997 Carcinogenesis 18: 137–147
Vähäkangas KH, Bennett WP, Castrén K, Welsh JA, Khan MA, Blömeke B, Alavanja MC, Harris CC . 2001 Cancer Res 61: 4350–4356
Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly A, Golka K, Okkels H, Risch A, Rothman N, Sim E, Taioli E . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 1249–1252
Walker DR, Bond JP, Tarone RE, Harris CC, Makalowski W, Boguski MS, Greenblatt MS . 1999 Oncogene 18: 211–218
Wang M, McIntee E, Cheng G, Shi X, Villalta P, Hecht S . 2000a Chem. Res. Toxicol. 13: 1149–1157
Wang M, McIntee E, Cheng G, Shi Y, Villalta P, Hecht S . 2000b Chem. Res. Toxicol. 13: 1065–1074
Wang M, McIntee E, Cheng G, Shi Y, Villalta P, Hecht S . 2001a Chem. Res. Toxicol. 14: 423–430
Wang M, McIntee E, Shi Y, Cheng G, Upadhyaya P, Villalta P, Hecht S . 2001b Chem. Res. Toxicol. 14: 1435–1445
Wei SJ, Chang RL, Bhachech N, Cui XX, Merkler KA, Wong CQ, Hennig E, Yagi H, Jerina DM, Conney AH . 1993 Cancer Res. 53: 3294–3301
Weisenberger DJ, Romano LJ . 1999 J. Biol. Chem. 274: 23948–23955
Wilson VL, Weston A, Manchester DK, Trivers GE, Roberts DW, Kadlubar FF, Wild CP, Montesano R, Willey JC, Mann DL . 1989 Carcinogenesis 10: 2149–2153
Witschi H . 2000 Exp. Lung Res. 26: 743–755
World Health Organization. 1997 Tobacco or Health: A Global Status Report Geneva: WHO pp. 10–48
Yoon JH, Smith LE, Feng Z, Tang M, Lee CS, Pfeifer GP . 2001 Cancer Res. 61: 7110–7117
Zhang Y, Yuan F, Wu X, Rechkoblit O, Taylor JS, Geacintov NE, Wang Z . 2000 Nucleic Acids Res. 28: 4717–4724
Zhao C, Tyndyk M, Eide I, Hemminki K . 1999 Mutation Res. 424: 117–125
Zhao C, Vodicka P, Sram R, Hemminki K . 2000 Carcinogenesis 21: 107–111
Acknowledgements
The work of the authors was supported by grants from the National Institutes of Health (CA84469 to GP Pfeifer; CA-81301 and DA 13333 to SS Hecht). The IARC p53 database is supported by a grant from the European Community (QLG-1999-00273).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Pfeifer, G., Denissenko, M., Olivier, M. et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21, 7435–7451 (2002). https://doi.org/10.1038/sj.onc.1205803
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205803
Keywords
This article is cited by
-
Treatments and whole exon sequencing of a case with multiple primary lung cancer
Journal of Cardiothoracic Surgery (2023)
-
E-liquid alters oral epithelial cell function to promote epithelial to mesenchymal transition and invasiveness in preclinical oral squamous cell carcinoma
Scientific Reports (2023)
-
Wound healing: An overview
BDJ Student (2023)
-
Arsenic, polycyclic aromatic hydrocarbons, and metal exposure and risk assessment of stroke
Environmental Science and Pollution Research (2023)
-
Demystifying the black box: from ignorance to observation to mechanism in cancer research
European Journal of Epidemiology (2023)